Indication: Advanced transitional cell carcinoma of the urothelium
Submitted for review:
Decision made on:
Outcome: Funded June 2006
GemcitabineIndication: Advanced transitional cell carcinoma of the urotheliumSubmitted for review: Decision made on: Outcome: Funded June 2006 »
|
About UsInformation |